Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Elan to sell European assets

December 12, 2003 Sales and Marketing Elan

Indebted Irish pharmaceutical company Elan has confirmed that it is in talks to sell part of its European operations.The company …
News

Pharma companies to licence AIDS drugs

December 12, 2003 Sales and Marketing

Cheaper AIDS drugs should soon be available in South Africa after two pharma companies agreed to licence their products to …
News

Outlook bright for generics

December 11, 2003 Sales and Marketing generics

Traditionally the US has been seen as the most attractive location for generics players with a combination of market fragmentation, …
Feature

Government promotes private access to Tamiflu

December 8, 2003 Sales and Marketing

The government has proposed making Roche's flu drug Tamiflu available to more patients through a private prescription from their GP.The …
News

Zetia-Zocor marketing to focus on efficacy

December 8, 2003 Sales and Marketing

Merck and Schering-Plough have indicated that efficacy and not safety will be the focus of their up-and-coming cholesterol combination drug.Merck …
News

Don’t get frozen out

December 4, 2003 Sales and Marketing marketing, sales, strategy

A fundamental change is underway in the European healthcare sector. The traditional autonomy of the physician has yielded to more …
Feature

Biotech grows up

December 4, 2003 Research and Development, Sales and Marketing alliances, biotech, partnerships, pharma

Sometimes it is hard to see where the fun lies in running a biotechnology company. Discounting the obvious success stories …
Feature

Making the most of medicines

November 26, 2003 Sales and Marketing NHS, healthcare, medicines management

Feature

Teva stretches lead in generics

November 5, 2003 Sales and Marketing

Teva has agreed to acquire US generics company Sicor for $3.4 billion and increased its third quarter profits 63%, led …
News

Making the switch

November 5, 2003 Sales and Marketing P, POM, switch

Switching is not a given and a successful POM to P transition requires considerable research and planning to extend unique …
Feature

GSK looks to consolidate UK lead with Avandamet

November 4, 2003 Sales and Marketing

News

Paxil patent blow for GSK

November 4, 2003 Sales and Marketing

News

Crestor goes head-to-head with Lipitor

November 4, 2003 Sales and Marketing

News

Generic threat to Lilly’s biggest seller

November 3, 2003 Sales and Marketing

A court challenge to Eli Lilly's patent on its number one drug Zyprexa could spell serious trouble for the company, …
News

Industry lukewarm on new labelling guidelines

October 31, 2003 Sales and Marketing

New guidelines on the labelling of medicines have received a cautious welcome from the pharma industry.The Government hopes the best …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026